Latest Insider Transactions at Sea Spine Holdings Corp (SPNE)
This section provides a real-time view of insider transactions for Sea Spine Holdings Corp (SPNE). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of SeaSpine Holdings Corp to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of SeaSpine Holdings Corp's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 02
2021
|
Renee Gaeta Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,253
+19.69%
|
-
|
|
Jun 02
2021
|
John B Henneman Iii Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,253
+8.57%
|
-
|
|
Jun 02
2021
|
Shweta Maniar Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,253
+34.57%
|
-
|
|
Jun 02
2021
|
Kirtley C. Stephenson Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,754
+7.67%
|
-
|
|
Apr 01
2021
|
Shweta Maniar Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,583
+50.0%
|
-
|
|
Mar 31
2021
|
Keith Bradley Director |
SELL
Payment of exercise price or tax liability
|
Direct |
42
-0.07%
|
$714
$17.4 P/Share
|
|
Mar 31
2021
|
Keith Bradley Director |
BUY
Grant, award, or other acquisition
|
Direct |
933
+1.45%
|
-
|
|
Mar 31
2021
|
Kirtley C. Stephenson Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,077
+1.1%
|
-
|
|
Mar 31
2021
|
Stuart Essig Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,293
+0.3%
|
-
|
|
Mar 31
2021
|
Renee Gaeta Director |
BUY
Grant, award, or other acquisition
|
Direct |
718
+3.6%
|
-
|
|
Mar 08
2021
|
Renee Gaeta Director |
SELL
Open market or private sale
|
Direct |
2,920
-13.61%
|
$52,560
$18.28 P/Share
|
|
Feb 22
2021
|
Renee Gaeta Director |
SELL
Open market or private sale
|
Direct |
3,000
-12.27%
|
$51,000
$17.76 P/Share
|
|
Jan 01
2021
|
John J. Bostjancic Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
12,851
-12.2%
|
$218,467
$17.45 P/Share
|
|
Jan 01
2021
|
John J. Bostjancic Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
23,471
+7.28%
|
-
|
|
Jan 01
2021
|
Patrick L Keran SVP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
11,308
-14.24%
|
$192,236
$17.45 P/Share
|
|
Jan 01
2021
|
Patrick L Keran SVP, General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
20,540
+8.32%
|
-
|
|
Jan 01
2021
|
Dennis Cirino SVP, Global Spinal Systems |
SELL
Payment of exercise price or tax liability
|
Direct |
5,137
-16.23%
|
$87,329
$17.45 P/Share
|
|
Jan 01
2021
|
Dennis Cirino SVP, Global Spinal Systems |
BUY
Exercise of conversion of derivative security
|
Direct |
8,773
+12.98%
|
-
|
|
Jan 01
2021
|
John J. Winge Vice President, Sales |
SELL
Payment of exercise price or tax liability
|
Direct |
9,090
-10.51%
|
$154,530
$17.45 P/Share
|
|
Jan 01
2021
|
John J. Winge Vice President, Sales |
BUY
Exercise of conversion of derivative security
|
Direct |
18,939
+7.08%
|
-
|
|
Jan 01
2021
|
Keith Valentine Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
25,450
-7.75%
|
$432,650
$17.45 P/Share
|
|
Jan 01
2021
|
Keith Valentine Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
47,399
+4.72%
|
-
|
|
Jan 01
2021
|
Tyler Lipschultz SVP, Orthobiologics and BD |
SELL
Payment of exercise price or tax liability
|
Direct |
11,349
-9.35%
|
$192,933
$17.45 P/Share
|
|
Jan 01
2021
|
Tyler Lipschultz SVP, Orthobiologics and BD |
BUY
Exercise of conversion of derivative security
|
Direct |
24,477
+6.59%
|
-
|
|
Dec 31
2020
|
Keith Valentine Chief Executive Officer |
BUY
Other acquisition or disposition
|
Direct |
1,058
+0.38%
|
$8,464
$8.92 P/Share
|
|
Dec 31
2020
|
Tyler Lipschultz SVP, Orthobiologics and BD |
BUY
Other acquisition or disposition
|
Direct |
1,134
+1.16%
|
$9,072
$8.92 P/Share
|
|
Dec 31
2020
|
Kirtley C. Stephenson Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,074
+1.11%
|
-
|
|
Dec 31
2020
|
Stuart Essig Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,289
+0.3%
|
-
|
|
Dec 31
2020
|
Keith Bradley Director |
SELL
Payment of exercise price or tax liability
|
Direct |
42
-0.07%
|
$714
$17.45 P/Share
|
|
Dec 31
2020
|
Keith Bradley Director |
BUY
Grant, award, or other acquisition
|
Direct |
931
+1.47%
|
-
|
|
Dec 31
2020
|
Renee Gaeta Director |
BUY
Grant, award, or other acquisition
|
Direct |
716
+2.84%
|
-
|
|
Sep 30
2020
|
Keith Bradley Director |
SELL
Payment of exercise price or tax liability
|
Direct |
52
-0.08%
|
$728
$14.3 P/Share
|
|
Sep 30
2020
|
Keith Bradley Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,136
+1.81%
|
-
|
|
Sep 30
2020
|
Renee Gaeta Director |
BUY
Grant, award, or other acquisition
|
Direct |
874
+3.55%
|
-
|
|
Sep 30
2020
|
Stuart Essig Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,573
+0.36%
|
-
|
|
Sep 30
2020
|
Kirtley C. Stephenson Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,311
+1.37%
|
-
|